This document provides guidelines for treating diabetic ketoacidosis (DKA) in children and adolescents. It recommends:
1. Using capillary blood ketone measurements during treatment and reducing the degree of dehydration used to calculate fluid needs.
2. Starting intravenous fluids for at least an hour before beginning insulin at 0.1 units/kg/hour, and continuing insulin even after blood glucose falls below 14 mmol/L.
3. Providing potassium with rehydration fluids at 20 mmol/L and monitoring electrolytes frequently, using cardiac monitoring for changes.
4. Carefully monitoring patients for cerebral edema, a potentially fatal complication, and treating it urgently with hypertonic saline or
This is the fifth lecture. it is based on guidelines by NHS UK. the guidelines based are freely available in internet. the source and the used literature are trusted and accurate. i hope this level of a knowledge about the management side of the DKA touches the all areas of patient survival. patho-physiology not discussed here but will be discussed in another lecture in details. to a intern and final year MBBS students or ERPM students must process a level of knowledge described by the lecture. definitely more you read more knowledge you get. get the idea in the lecture and principles of management. so you will be much accurate in a ward. always take superior advice while managing emergencies.
Potassium is the principal cation of the intracellular fl uid
(ICF) where its concentration is between 120 and 150 mEq/L.
The extracellular fl uid (ECF) and plasma potassium concentration [K] is much lower––in the 3.5–5.0 mEq/L range.
The very large transcellular gradient is maintained by active
K transport via the Na-K-ATPase pumps present in all cell
membranes and the ionic permeability characteristics of
these membranes. The resulting greater than 40-fold transmembrane [K] gradient is the principal determinant of the
transcellular resting potential gradient, about 90 mV with
the cell interior negative . Normal cell function
requires maintenance of the ECF [K] within a relatively narrow
range. This is particularly important for excitable cells
such as myocytes and neurons. The pathophysiologic effects
of dyskalemia on these cells result in most of the clinical
manifestations.
This is the fifth lecture. it is based on guidelines by NHS UK. the guidelines based are freely available in internet. the source and the used literature are trusted and accurate. i hope this level of a knowledge about the management side of the DKA touches the all areas of patient survival. patho-physiology not discussed here but will be discussed in another lecture in details. to a intern and final year MBBS students or ERPM students must process a level of knowledge described by the lecture. definitely more you read more knowledge you get. get the idea in the lecture and principles of management. so you will be much accurate in a ward. always take superior advice while managing emergencies.
Potassium is the principal cation of the intracellular fl uid
(ICF) where its concentration is between 120 and 150 mEq/L.
The extracellular fl uid (ECF) and plasma potassium concentration [K] is much lower––in the 3.5–5.0 mEq/L range.
The very large transcellular gradient is maintained by active
K transport via the Na-K-ATPase pumps present in all cell
membranes and the ionic permeability characteristics of
these membranes. The resulting greater than 40-fold transmembrane [K] gradient is the principal determinant of the
transcellular resting potential gradient, about 90 mV with
the cell interior negative . Normal cell function
requires maintenance of the ECF [K] within a relatively narrow
range. This is particularly important for excitable cells
such as myocytes and neurons. The pathophysiologic effects
of dyskalemia on these cells result in most of the clinical
manifestations.
11 most common pitfalls in the management of DKA including diagnosis, when to call ICU team, potassium replacement, fluid replacement, transition to subcutaneous insulin, post DKA management including follow up after discharge
This presentation is based on JBDS and BSPDE guidelines in adult and Paediatric DKA management. A comparison of adult vs paediatric management is included.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Dka picu
1. DIABETIC KETOACIDOSIS
ISPAD Clinical Practice Consensus Guidelines
2009 Compendium
Diabetic ketoacidosis in children and
adolescents with diabetes
Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J,
Lee W, Rosenbloom A, Sperling M, and Hanas R.
Pediatric Diabetes 2009: 10 (Suppl. 12): 118–133.
2. DIABETIC KETOACIDOSIS
BSPED Recommended DKA Guidelines 2009
WORKING GROUP OF THE BRITISH SOCIETY OF
PAEDIATRIC ENDOCRINOLOGY AND DIABETES
Dr. Julie Edge, Consultant in Paediatric Diabetes,
Oxford Children’s Hospital,
• 1. Recommendation to use capillary blood
ketone measurement during treatment
• 2. Reduction in the degree of dehydration to be
used to calculate fluids
• 3. Reduction in maintenance fluid rates
3. DIABETIC KETOACIDOSIS
BSPED Recommended DKA Guidelines 2009
• 4. Change in the recommendations for PICU/HDU –
more emphasis on safe nursing on general wards
• 5. Continuation of Normal saline for the first 12
hours of rehydration
• 6. Delay in insulin until fluids have been running for
an hour
• 7. Option to continue insulin glargine during
treatment
4. DIABETIC KETOACIDOSIS
BSPED Recommended DKA Guidelines 2009
• 8. Reminder to stop insulin pump therapy during
treatment
• 9. Reminder to consider anticoagulant prophylaxis
in young children, especially those with femoral
lines
• 10. Interpretation of blood ketone measurements if
pH not improving
• 11. Option to use hypertonic saline instead of
mannitol for the treatment of cerebral oedema
5. DIABETIC KETOACIDOSIS
BSPED Recommended DKA Guidelines 2009
CAUTION
These guidelines are believed to be as safe
as possible in the light of current evidence.
However, no guidelines can be considered
entirely safe as complications may still
arise. In particular the pathophysiology of
cerebral oedema is still poorly understood.
6. A. GENERAL :
• Always consult with a more senior doctor on
call as soon as you suspect DKA even if you
feel confident of your management.
Remember : children can die from DKA.
They can die from –
• Cerebral oedema
• Hypokalaemia
• Aspiration pneumonia
7. Definition:
• children and young people who have:
• hyperglycaemia (BG >11 mmol/l)
• pH < 7.3
• bicarbonate < 15 mmol/l and who are
more than 3% dehydrated
and/or vomiting
and/or drowsy
and/or clinically acidotic
• Children who are 5% dehydrated or less and not clinically unwell (mild acidosis and not
nauseated or vomiting) usually tolerate oral rehydration and subcutaneous insulin.
8. B. EMERGENCY
MANAGEMENT IN A & E :
• 1. General Resuscitation : A, B, C.
Only if shocked (poor peripheral pulses, poor capillary filling with
tachycardia, and/or hypotension) give 10 ml/kg 0.9% saline as a
bolus, and repeat as necessary to a maximum of 30 ml/kg.
• 2. Confirm the Diagnosis :
• 3. Initial Investigations :
blood glucose urea and electrolytesblood gases near
patient blood ketones + other investigations only if
indicated e.g. PCV and full blood count, CXR, CSF, throat
swab, blood culture, urinalysis, c and s etc. (DKA may
rarely be ppted by sepsis, and fever is not part of DKA.)
9. C. FULL CLINICAL ASSESSMENT
AND OBSERVATIONS :
• 1. Degree of Dehydration –
Over-estimation of degree of dehydration is dangerous.
Therefore do not use more than 8% dehydration in calculations
• 2. Conscious Level –
Institute hourly neurological observations including G C S whether or not drowsy on admission.
• 3. Full Examination - looking particularly for evidence of
- cerebral oedema infection ileus
WEIGH THE CHILD. If this is not possible because of the clinical condition, use the
most recent clinic weight as a guideline, or an estimated weight from centile charts.
10. C. FULL CLINICAL ASSESSMENT
AND OBSERVATIONS :
4. Consider PICU or HDU for the following, and
discuss with a PICU consultant.
• severe acidosis pH<7.1 with marked hyperventilation
• severe dehydration with shock
• depressed sensorium with risk of aspiration from
vomiting
• very young (under 2 years)
• staffing levels on the wards are insufficient to allow
adequate monitoring
11. C. FULL CLINICAL ASSESSMENT
AND OBSERVATIONS :
5. Observations to be carried out : recording all results and clinical
signs on a flow chart.
• strict fluid balance
• measurement of volume of every urine sample
• hourly capillary blood glucose measurements
• capillary blood ketone levels every 1-2 hours (if available)
• urine testing for ketones (if blood ketone testing not available)
• hourly BP and basic observations
• twice daily weight; can be helpful in assessing fluid balance
• hourly or more frequent neurological observations initially
• reporting immediately to the medical staff, even at night, symptoms of
headache, or slowing of pulse rate, or any change in either conscious level or
behaviour
• reporting any changes in the ECG trace, especially T wave changes suggesting
hyper- or hypokalaemia
12. D. MANAGEMENT :
1. FLUIDS :
• a) Volume of fluid –
Requirement = Maintenance + Deficit – fluid already given
For most children, use 5% to 8% dehydration to calculate fluids.
Maintenance requirements:
Weight 0 – 12.9 kg 80 ml/kg/24 hrs
13 – 19.9 kg 65 ml/kg/24 hrs
20 – 34.9 kg 55 ml/kg/24 hrs
35 – 59.9 kg 45 ml/kg/24 hrs
adult (>60 kg) 35 ml/kg/24 hrs
N.B. Neonatal DKA will require special consideration and larger volumes of fluid
than those quoted may be required, usually 100-150 ml/kg/24 hours)
14. D. MANAGEMENT :
1. FLUIDS :
b) Type of fluid -
• Initially use 0.9% saline with 20 mmol KCl in 500 ml, and continue
this sodium concentration for at least 12 hours.
• Once the blood glucose has fallen to 14 mmol/l add glucose to the
fluid. After 12 hours, if the plasma sodium level is stable or
increasing, change to 500ml bags of 0.45% saline/5% glucose/20
mmol KCl.
• If the plasma sodium is falling, continue with Normal saline (with or
without glucose depending on blood glucose levels).
• Corrected sodium levels should rise as blood glucose levels fall
during treatment. If they do not, then continue with Normal saline and
do not change to 0.45% saline.
15. D. MANAGEMENT :
1. FLUIDS :
c) Oral Fluids :
• In severe dehydration, impaired consciousness &
acidosis do not allow fluids by mouth. A N/G tube may be
necessary in the case of gastric paresis.
• Oral fluids (eg fruit juice/oral rehydration solution)
should only be offered after substantial clinical
improvement and no vomiting
• When good clinical improvement occurs before the 48hr
rehydration period is completed, oral intake may proceed
and the need for IV infusions reduced to take account of
the oral intake.
16. D. MANAGEMENT :
2. POTASSIUM :
• Once the child has been resuscitated, potassium should be
commenced immediately with rehydration fluid unless
anuria is suspected. Therefore ensure that every 500 ml bag
of fluid contains 20 mmol KCl (40 mmol per litre).
• Check U & E's 2 hours after resuscitation is begun and then
at least 4 hourly, and alter potassium replacements
accordingly. More potassium than 40 mmol/l is occasionally
required.
• Use a cardiac monitor and observe frequently for T wave
changes.
17. D. MANAGEMENT :
3. INSULIN :
DO NOT start insulin until intravenous fluids have been running for
at least an hour.
• Continuous low-dose intravenous infusion is the preferred
method. 0.1 units/kg/hour Do not add insulin directly to the fluid bags.
• Once the blood glucose level falls to 14mmol/l, change the fluid to
contain 5% glucose (generally 0.9% saline with glucose and
potassium). DO NOT reduce the insulin.
• DO NOT stop the insulin infusion while glucose is being infused,
as insulin is required to switch off ketone production. If the blood
glucose falls below 4 mmol/l, give a bolus of 2 ml/kg of 10%
glucose and increase the glucose concentration of the infusion.
Insulin can temporarily be reduced for 1 hour.
18. D. MANAGEMENT :
• 4. BICARBONATE :
• Bicarbonate should only be considered in children who are profoundly acidotic
(pH< 6.9) and shocked with circulatory failure. Its only purpose is to improve
cardiac contractility in severe shock.
• Before starting bicarbonate, discuss with senior staff, and the quantity should be
decided by the paediatric resuscitation team or consultant on-call.
• 5. PHOSPHATE :
• There is always depletion of phosphate. There is no evidence in adults or children
that replacement has any clinical benefit and phosphate administration may lead to
hypocalcaemia.
• 6. ANTICOAGULANT PROPHYLAXIS :
• There is a significant risk of femoral vein thrombosis in young and very sick
children with DKA who have femoral lines inserted. Therefore consideration should
be given to anticoagulating these children with 100 units/kg/day as a single daily
dose of Fragmin.
• Children who are significantly hyperosmolar might also require anticoagulant
prophylaxis
19. E. CONTINUING MANAGEMENT
Urinary catheterisation should be avoided but may be useful in the child
with impaired consciousness.
Documentation of fluid balance is of paramount importance.
If a massive diuresis continues fluid input may need to be increased.
If large volumes of gastric aspirate continue, these will need to be replaced with
0.45% saline with KCl.
Check biochemistry, blood pH, and laboratory blood glucose 2 hours
after the start of resuscitation, and then at least 4 hourly. Review the
fluid composition and rate according to each set of electrolyte results.
If acidosis is not correcting, consider the following
• insufficient insulin to switch off ketones inadequate resuscitation
• sepsis hyperchloraemic acidosissalicylate or other prescription
or recreational drugs
20. E. CONTINUING MANAGEMENT
• Use near-patient ketone testing to confirm that ketone levels are falling
adequately. If blood ketones are not falling, then check infusion lines, the
calculation and dose of insulin and consider giving more insulin.
• Consider sepsis, inadequate fluid input and other causes if sufficient insulin is being
given.
• Insulin management once ketoacidosis resolved -
• Continue with IV fluids until the child is drinking well and able to
tolerate food. Only change to subcutaneous insulin once blood ketone
levels are below 1.0 mmol/l, although urinary ketones may not have
disappeared completely.
• Discontinue the insulin infusion 60 minutes (if using soluble or long-
acting insulin) or 10 minutes (if using Novorapid or Humalog) after
the first subcutaneous injection to avoid rebound hyperglycaemia.
Subcutaneous insulin should be started according to local protocols for the child
with newly diagnosed diabetes, or the child should be started back onto their usual
insulin regimen at an appropriate time
21. F. Cerebral Edema
The signs and symptoms of
cerebral oedema include
• headache & slowing of heart rate
• change in neurological status
(restlessness,irritability, increased drowsiness,
incontinence)
• specific neurological signs
(eg. cranial nerve palsies)
• rising BP, decreased O2 saturation
• abnormal posturing Late
More dramatic changes such as convulsions, Sequelae
papilloedema, respiratory arrest are late signs
associated with extremely poor prognosis
22. F. Cerebral Edema
• Management : If cerebral oedema is suspected
inform senior staff immediately.
exclude hypoglycaemia as a possible cause of any behaviour change
give hypertonic (2.7%) saline (5mls/kg over 5-10 mins) or Mannitol
0.5 – 1.0 g/kg stat (20% Mannitol over 20 minutes).
restrict IV fluids to 1/2 maintenance and replace deficit over 72 rather
than 48 hours
the child will need to be moved to PICU- discuss with PICU consultant. Do not
intubate and ventilate until an experienced doctor is available
once the child is stable, exclude other diagnoses by CT scan - other
intracerebral events may occur (thrombosis, haemorrhage or infarction)
a repeated dose of Mannitol may be required after 2 hours if no response
document all events (with dates and times) very carefully in medical
records
23. G. OTHER COMPLICATIONS :
• Hypoglycaemia and hypokalaemia – avoid by careful monitoring and
adjustment of infusion rates. Consideration should be given to adding more glucose
if BG falling quickly even if still above 4 mmol/l.
• Systemic Infections – Antibiotics are not given as a routine unless a severe
bacterial infection is suspected
• Aspiration pneumonia – avoid by nasogastric tube in vomiting child with
impaired consciousness
– Other associations with DKA require specific management:
• Continuing abdominal pain ( may be due to liver swelling, gastritis,
bladder retention, ileus. However, beware of appendicitis and ask for a
surgical opinion ). A raised amylase is common in DKA.
• Other problems are pneumothorax ± pneumo-mediastinum,
interstitial pulmonary oedema, unusual infections (eg TB, fungal
infections), hyperosmolar hyperglycaemic non–ketotic coma,
ketosis in type 2 diabetes.
• Discuss these with the consultant on-call.